Sam Hanash leads discovery of blood proteins associated with early development of lung cancer; findings hold promise of a blood test for screening, diagnosis
Sept. 19, 2011
| By Kristen Woodward
A Fred Hutchinson Cancer Research Center team has discovered proteins in the blood that are associated with early lung cancer development in mice and humans. The advance brings the reality of a blood test for the early detection and diagnosis of lung cancer a step closer.
Janet Stanford leads first population-based study to identify and validate five inherited genetic variants strongly associated with prostate cancer progression and mortality
Aug. 22, 2011
| By Kristen Woodward
An international team of researchers led by Dr. Janet Stanford, co-director of the Fred Hutchinson Cancer Research Center’s Program in Prostate Cancer Research, has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer. The discovery ultimately could lead to the development of a simple blood test that could be given upon diagnosis to determine which men should receive aggressive treatment versus a more conservative "watchful waiting" approach.
First round of funding from The Lustgarten Foundation will support pancreas cancer research at six U.S. institutions
June 29, 2009
Dr. Sunil Hingorani of the Fred Hutchinson Cancer Research Center is among investigators at six leading research centers who will share $1.6 million in the first round of 2009 funding from The Lustgarten Foundation, the country’s largest private foundation working solely on pancreas cancer research. The awards will fund studies on early diagnostic tests and improved treatment for one of the nation's deadliest cancers.
Human Biology researcher focuses on microRNAs made by tumor cells as potential early detection targets
Jan. 26, 2009
Dr. Muneesh Tewari, of the Fred Hutchinson Cancer Research Center's Human Biology Division, has received $450,000 over three years from the Damon Runyon Cancer Research Foundation to pursue early detection research for lung and other cancers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.